Wal-Mart adds 12 states to its drug plan

updated 8:05 a.m. ET Oct. 26, 2006

LITTLE ROCK, Ark. - Wal-Mart Stores Inc., the world’s biggest retailer, said Thursday it is extending its $4 generic prescription drug plan to another 12 states, bringing to total to 27 states.

The move brings 1,008 more stores under the program, under which Wal-Mart charges $4 for a one-month supply of 314 different prescriptions. That number includes 143 drugs in a variety of dosages and solid or liquid forms.

Bentonville, Ark.-based Wal-Mart rolled out the program in Florida three weeks ago and last week added 14 states to the list. The low-priced drugs are now available in 2,507 Wal-Mart, Sam’s Club and Neighborhood Market stores.

The company said in a news release that it accelerated the launch of the low-priced prescriptions because of customer demand.

Analysts say the program will help Wal-Mart by bringing in more customers who will shop in other store departments, and extend its reach in another segment of the retailing industry - the drug store business.

Union-backed Wal-Mart critics have also accused the company of using the low-priced drugs to divert attention from its own employee health insurance plan, which anti-Wal-Mart groups say does not offer adequate coverage.

States added Thursday were: Alabama, Georgia, Iowa, Kansas, Maryland, Michigan, Mississippi, Missouri, New Hampshire, Ohio, South Dakota and Virginia.

States already with the program were: Alaska, Arkansas, Arizona, Delaware, Florida, Illinois, Indiana, Nevada, New Jersey, New Mexico, New York, North Carolina, Oregon, Texas and Vermont.

MORE FROM U.S. BUSINESS

U.S. business Section Front

Source: Madoff leaves NYC jail to begin prison Trusting the brand to the lowly ‘twintern’   U.S. Bancorp also won’t honor California IOUs Publisher exploring options for BusinessWeek CIT in talks with regulators over liquidity Recession makes it easier to catch scammers Ex-Stanford exec enters plea in swindle case Obama urges patience on stimulus plan Five companies to watch this earnings season Geithner: Stimulus is on the right path U.S. business Section Front   Add U.S. business headlines to your news reader: